Home/Filings/4/0001179110-15-012987
4//SEC Filing

HOSPIRA INC 4

Accession 0001179110-15-012987

CIK 0001274057operating

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 12:06 PM ET

Size

40.9 KB

Accession

0001179110-15-012987

Insider Transaction Report

Form 4
Period: 2015-09-03
Werner Thomas E
SVP and CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2015-09-03$28.95/sh+73,171$2,118,300374,867 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-0320,0000 total
    Exercise: $38.13Exp: 2016-09-28Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-0332,5310 total
    Exercise: $52.61Exp: 2018-02-23Common Stock (32,531 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-0369,8600 total
    Exercise: $35.36Exp: 2019-02-28Common Stock (69,860 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-0353,3330 total
    Exercise: $42.70Exp: 2021-02-25Common Stock (53,333 underlying)
  • Exercise/Conversion

    Phantom Shares

    2015-09-03664.740 total(indirect: Phantom Shares held in non-qualified savings and investment plan)
    Common Stock (664.74 underlying)
  • Award

    Common Stock

    2015-09-03+20,243109,015 total
  • Award

    Common Stock

    2015-09-03+11,007120,022 total
  • Award

    Common Stock

    2015-09-03+12,066132,088 total
  • Exercise/Conversion

    Common Stock

    2015-09-03$38.13/sh+20,000$762,600152,088 total
  • Exercise/Conversion

    Common Stock

    2015-09-03$49.64/sh+40,541$2,012,455192,629 total
  • Exercise/Conversion

    Common Stock

    2015-09-03$52.61/sh+32,531$1,711,456231,836 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-036,6760 total
    Exercise: $53.30Exp: 2017-08-17Common Stock (6,676 underlying)
  • Exercise/Conversion

    Common Stock

    2015-09-03+664.74664.74 total(indirect: Phantom Shares held in deferred compensation plan)
  • Disposition to Issuer

    Common Stock

    2015-09-03664.740 total(indirect: Phantom Shares held in deferred compensation plan)
  • Exercise/Conversion

    Common Stock

    2015-09-03$42.70/sh+53,333$2,277,319428,200 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-0340,5410 total
    Exercise: $49.64Exp: 2017-02-10Common Stock (40,541 underlying)
  • Exercise/Conversion

    Common Stock

    2015-09-03$53.30/sh+6,676$355,831199,305 total
  • Exercise/Conversion

    Common Stock

    2015-09-03$35.36/sh+69,860$2,470,250301,696 total
  • Disposition to Issuer

    Common Stock

    2015-09-03$90.00/sh428,200$38,538,0000 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-09-0373,1710 total
    Exercise: $28.95Exp: 2020-02-26Common Stock (73,171 underlying)
Footnotes (11)
  • [F1]Conversion of phantom shares that were acquired under Hospira's Non-Qualified Savings and Investment Plan, a non-qualified deferred compensation plan. Each share of phantom stock is the economic equivalent of one share of common stock. The vested shares of phantom stock become payable in cash, based upon the account balance at the time of distribution upon the earlier of a date specified by the reporting person or upon a change in control.
  • [F10]Exercise of stock options granted on 2/27/2013, which vest in four annual installments on February 27, 2014, 2015, 2016 and 2017. The vesting of the last two tranches of options was accelerated in connection with the change of control.
  • [F11]Exercise of stock options granted on 2/26/2014, which vest in four annual installments on February 26, 2015, 2016, 2017 and 2018. The vesting of the last three tranches of options was accelerated in connection with the change of control.
  • [F2]Vesting of performance share units for the 2013-2015 performance cycle. The award provided for vesting based on achievement of total shareholder return over a three year performance period relative to the performance of a pre-established peer group, or upon a change of control. Thus, the units vested on September 3, 2015.
  • [F3]Vesting of performance share units for the 2014-2016 performance cycle. The award provided for vesting based on achievement of total shareholder return over a three year performance period relative to the performance of a pre-established peer group, or upon a change of control. Thus, the units vested on September 3, 2015.
  • [F4]Vesting of a performance-contingent restricted stock units award granted February 27, 2013. The units were earned when Hospira's stock price appreciated 20% over the fair market value on the date of grant, and maintained that price for a 30 consecutive trading day period (based on Hospira's closing market price on those 30 consecutive days). Since the units were earned, the award provided for three-year time based cliff vesting, or upon a change of control. Thus, vesting of the units was accelerated upon a change of control.
  • [F5]Exercise of stock options granted on 9/29/2006, which vested in four equal installments on September 29, 2007, 2008, 2009 and 2010. The stock options expire in ten years, or September 28, 2016.
  • [F6]Exercise of stock options granted on 2/11/2010, which vested in three equal installments on February 11, 2011, 2012 and 2013.
  • [F7]Exercise of stock options granted on 08/18/10, which vested in three equal installments on August 18, 2011, 2012 and 2013.
  • [F8]Exercise of stock options granted on 2/24/2011, which vested in four equal installments on February 24, 2012, 2013, 2014 and 2015.
  • [F9]Exercise of stock options granted on 3/1/2012, which vest in four equal installments on March 1, 2013, 2014, 2015, and 2016. The vesting of the last tranche of options was accelerated in connection with the change of control.

Issuer

HOSPIRA INC

CIK 0001274057

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001274057

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 12:06 PM ET
Size
40.9 KB